Regenxbio plans USD 100 million common stock offering to raise capital - RGNX News | RalliesRegenxbio plans USD 100 million common stock offering to raise capital
R
RGNX• Planned common stock offering
- Regenxbio plans an underwritten public offering of USD 100 million of common stock, subject to market conditions.
- Underwriters will receive a 30-day option to buy up to 15% more shares than the base deal size.
- Morgan Stanley, J.P. Morgan, Leerink Partners, and Mizuho will act as joint book-running managers.
•
